Wolverine Trading, LLC Cti Biopharma Corp Transaction History

Wolverine Trading, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$4.2 - $6.01 $66,208 - $94,741	15,764 New	15,764 $67,000
Q3 2022 Nov 14, 2022	BUY	$5.36 - $7.43 $121,345 - $168,207	22,639 New	22,639 $127,000
Q2 2022 Aug 15, 2022	SELL	$3.55 - $6.27 $167,496 - $295,831	-47,182 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.9 - $5.23 $55,219 - $151,999	29,063 Added 160.4%	47,182 $236,000
Q4 2021 Feb 14, 2022	SELL	$1.44 - $2.86 $7,392 - $14,683	-5,134 Reduced 22.08%	18,119 $45,000

Q3 2021 Nov 12, 2021	BUY	$2.25 - $3.18 $19,419 - $27,446	8,631 Added 59.03%	23,253 $68,000
Q3 2018 Nov 14, 2018	BUY	$1.72 - $5.24 $6,566 - $20,006	3,818 Added 35.34%	14,622 $32,000
Q1 2018 May 15, 2018	BUY	$2.7 - $4.06 $29,170 - $43,864	10,804 New	10,804 $42,000

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.